Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.578 SEK | -0.34% | +2.48% | -64.54% |
05-16 | ProstaLund AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-08 | ProstaLund AB Presents Two New Studies with Schelin Catheter | CI |
Valuation
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 85.61 | 105.4 | 112.6 | 213.3 | 228.5 | 124.8 |
Enterprise Value (EV) 1 | 83.53 | 96.02 | 102.7 | 200.3 | 217.9 | 110.8 |
P/E ratio | -6.31 x | -7.04 x | -9.89 x | -24.4 x | -19 x | -6.52 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 6.31 x | 8.18 x | 9.03 x | 12.5 x | 13.1 x | 5.62 x |
EV / Revenue | 6.16 x | 7.45 x | 8.24 x | 11.7 x | 12.5 x | 4.99 x |
EV / EBITDA | -6.56 x | -9.25 x | -10.4 x | -25.8 x | -20.2 x | -8.74 x |
EV / FCF | -12.8 x | -10.8 x | -12.2 x | -16.8 x | -13.9 x | -6.07 x |
FCF Yield | -7.82% | -9.28% | -8.2% | -5.94% | -7.19% | -16.5% |
Price to Book | 6.74 x | 4.74 x | 4.44 x | 6.02 x | 5.48 x | 2.26 x |
Nbr of stocks (in thousands) | 13,698 | 32,525 | 42,157 | 51,525 | 57,193 | 76,589 |
Reference price 2 | 6.250 | 3.240 | 2.670 | 4.140 | 3.995 | 1.630 |
Announcement Date | 19-04-09 | 20-03-27 | 21-04-06 | 22-04-11 | 23-04-04 | 24-04-19 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 13.57 | 12.89 | 12.46 | 17.07 | 17.41 | 22.21 |
EBITDA 1 | -12.74 | -10.38 | -9.877 | -7.755 | -10.76 | -12.68 |
EBIT 1 | -12.95 | -10.44 | -9.919 | -7.855 | -10.89 | -12.85 |
Operating Margin | -95.45% | -81% | -79.57% | -46.01% | -62.56% | -57.87% |
Earnings before Tax (EBT) 1 | -12.95 | -10.58 | -9.98 | -7.884 | -11.1 | -17.01 |
Net income 1 | -12.95 | -10.58 | -9.98 | -7.884 | -11.1 | -17.01 |
Net margin | -95.45% | -82.13% | -80.06% | -46.18% | -63.74% | -76.6% |
EPS 2 | -0.9900 | -0.4600 | -0.2700 | -0.1700 | -0.2100 | -0.2500 |
Free Cash Flow 1 | -6.535 | -8.912 | -8.422 | -11.89 | -15.66 | -18.27 |
FCF margin | -48.17% | -69.16% | -67.56% | -69.65% | -89.97% | -82.28% |
FCF Conversion (EBITDA) | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 19-04-09 | 20-03-27 | 21-04-06 | 22-04-11 | 23-04-04 | 24-04-19 |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | - | - |
Net Cash position 1 | 2.09 | 9.36 | 9.9 | 13 | 10.5 | 14 |
Leverage (Debt/EBITDA) | - | - | - | - | - | - |
Free Cash Flow 1 | -6.54 | -8.91 | -8.42 | -11.9 | -15.7 | -18.3 |
ROE (net income / shareholders' equity) | -97.8% | -60.6% | -41.9% | -25.9% | -28.8% | -35.1% |
ROA (Net income/ Total Assets) | -43.7% | -28.6% | -21.7% | -13.2% | -14.4% | -13.8% |
Assets 1 | 29.66 | 36.94 | 46.06 | 59.67 | 77.04 | 123.4 |
Book Value Per Share 2 | 0.9300 | 0.6800 | 0.6000 | 0.6900 | 0.7300 | 0.7200 |
Cash Flow per Share 2 | 0.2100 | 0.3000 | 0.2500 | 0.2600 | 0.2100 | 0.2000 |
Capex 1 | 0.01 | - | 0.31 | 0.2 | 0.15 | 0.15 |
Capex / Sales | 0.04% | - | 2.45% | 1.14% | 0.84% | 0.66% |
Announcement Date | 19-04-09 | 20-03-27 | 21-04-06 | 22-04-11 | 23-04-04 | 24-04-19 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-64.54% | 4.21M | |
-7.90% | 177B | |
-0.83% | 108B | |
-7.44% | 65.55B | |
+3.01% | 50.66B | |
+5.96% | 42.58B | |
+5.73% | 40.74B | |
+18.00% | 31.07B | |
+16.57% | 25.45B | |
-4.64% | 23.93B |
- Stock Market
- Equities
- PLUN Stock
- Financials ProstaLund AB